Recent News and Updates
A New Guidance on Wilson Disease
Diagnosis|Treatment|Monitoring By Rhonda Rowland This is a first for Wilson disease (WD). The new Practice Guidance on WD is a careful balance of combining limited scientific evidence with expert experience to create a tool for [...]
Ultragenyx’s Wilson Disease Gene Therapy Program Update
On behalf of the Ultragenyx Wilson disease study team, we would like to share a recent update on our CYPRUS2+ study. Ultragenyx has changed Stage 1 of our CYPRUS2+ study to an open-label, single [...]
Shipping Trientine to India through MAP International
The WDA is no longer able to ship Trientine to India through MAP International due to Indian rules. If you have any questions please contact: Dr Seema Alam Prof Pediatric Hepatology Department of Pediatric Hepatology [...]
Registration and availability of Trientine hydrochloride – Australia
Important Announcement – Registration and availability of Trientine dihydrochloride (AUST R 327984) Waymade Australia Pty Ltd wishes to advise that Trientine Waymade (Trientine dihydrochloride) 250mg capsule bottle (x100) was registered with the Therapeutics Goods [...]
Registration and availability of Trientine hydrochloride – Canada
IMPORTANT ANNOUNCEMENT Registration and availability of Trientine hydrochloride (Health Canada Drug Identification Number: 02515067 Waymade Canada Inc. wishes to advise that Waymade-Trientine (Trientine dihydrochloride) 250mg capsule bottle (x100) was registered with Health Canada on [...]
Notice of Medication Discontinuation
Due to changing market conditions, Kadmon is in the process of discontinuing its sales of CLOVIQUE® (trientine hydrochloride capsules, USP) blister packs. More information here.


